The Investor Relations website contains information about Arena Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
http://invest.arenapharm.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
0.5 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
14
SSL
EXTERNAL LINKS
144
SITE IP
23.55.218.214
LOAD TIME
0.451 sec
SCORE
6.2
Investors | Arena Pharmaceuticals, Inc. | invest.arenapharm.com Reviews
https://invest.arenapharm.com
The Investor Relations website contains information about Arena Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
invest.arenapharm.com
Email Alert Subscription ‹ Arena Pharmaceuticals, Inc.
http://invest.arenapharm.com/profile.cfm
Arena Pharmaceuticals, Inc. Step 1 of 3: Select Options. You may automatically receive Arena Pharmaceuticals, Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. All Events and Webcasts. In advance of any event. Unsubscribe from Investor Relations email alerts.
Corporate Governance ‹ Arena Pharmaceuticals, Inc.
http://invest.arenapharm.com/governance.cfm
Arena Pharmaceuticals, Inc. Governance Documents and Related Information. Our success is closely linked to the confidence we instill in others through the ethical and honest management of our company and accurate public reporting. It is the policy of Arena to promote high standards of integrity by conducting our affairs in an honest and ethical manner, and our Board of Directors and senior management team are firmly committed to effective corporate governance.
Press Releases ‹ Arena Pharmaceuticals, Inc.
http://invest.arenapharm.com/releases.cfm
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer. Aug 15, 2016. SAN DIEGO, Aug. 15, 2016 /PRNewswire/ - Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that Vincent Aurentz will join its management team as Executive Vice President and Chief Business Officer, effective today. Mr. Aurentz will report to Amit Munshi, Arena's President and Chief Executive Officer. "I am excited to have Vince join u. Aug 8, 2016. Aug 1, 2016. Eisai Inc&#...
Events & Presentations ‹ Arena Pharmaceuticals, Inc.
http://invest.arenapharm.com/events.cfm
Arena Pharmaceuticals, Inc. Details on upcoming events are not yet available. Aug 8, 2016. Arena Pharmaceuticals' Second Quarter 2016 Update. May 9, 2016. Arena Pharmaceuticals' First Quarter 2016 Update. Feb 29, 2016. Arena Pharmaceuticals' Fourth Quarter and Full Year 2015 Update. Jan 14, 2016. 34th Annual JPMorgan Healthcare Conference. Add file to Briefcase. Additional Information regarding Arena is available in its SEC filings.
Analyst Coverage ‹ Arena Pharmaceuticals, Inc.
http://invest.arenapharm.com/analysts.cfm
Arena Pharmaceuticals, Inc. Note: This page was last updated on May 23, 2016). You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Additional Information regarding Arena is available in its SEC filings.
TOTAL PAGES IN THIS WEBSITE
14
http://www.arenapharm.com/pipeline.aspx
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. 404 - Page Not Found. We're sorry, the Web address you entered is not a functioning page on our site. To return to the home page. If you feel something is missing that should be here, contact us. This page last updated: 05/20/2013. Additional Information regarding Arena is available in its SEC filings.
APD334 ‹ Arena Pharmaceuticals
http://www.arenapharm.com/apd334
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Drug Candidate for Treatment of Autoimmune Diseases. Etrasimod (APD334), an orally available S1P. Receptor modulator, discovered by Arena, has therapeutic potential in autoimmune diseases such as ulcerative colitis. S1P. Page for more information. Phase 2 Trial Ongoing. Etrasimod has not been approved by the US Food a...
GPCR FAQ ‹ Arena Pharmaceuticals
http://www.arenapharm.com/gpcr-faq
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Why are GPCRs important in human health? GPCRs play a crucial role in many diverse disease processes. The receptors have been linked to regulation of behavior and mood through GPCRs found in the brain, inflammation through receptors in the immune system, and metabolic processes, among others. What drugs target GPCRs?
GPCR Focus ‹ Arena Pharmaceuticals
http://www.arenapharm.com/gpcr-focus
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Our Drug Discovery Approach, Expertise and Technologies. We believe that our drug discovery approach, expertise and technologies offer several advantages for drug discovery, including:. Eliminating the need to identify the native ligand for an orphan receptor;. This page last updated: 5/20/2013.
Business Development ‹ Arena Pharmaceuticals
http://www.arenapharm.com/business-development
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. BELVIQ (lorcaserin HCl) Marketing and Supply Agreements. BELVIQ is approved by the US Food and Drug Administration and will be available in the US only after its Schedule IV designation is effective on June 7, 2013. Temanogrel Co-Development and License Agreement. This page last updated: 11/20/2015. All images are own...
Career Opportunities - Arena GmbH ‹ Arena Pharmaceuticals
http://www.arenapharm.com/career-opportunities-arena-gmbh
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. All offers of employment are subject to successful completion of a background verification. Sorry, there are no positions available through our website at this time. This page last updated: 5/20/2013.
Lorcaserin Lifecycle Management ‹ Arena Pharmaceuticals
http://www.arenapharm.com/lorcaserinLM
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Extended Release and CVOT. We and Eisai have prioritized the development areas of a once-daily formulation of lorcaserin, and evaluating, including as part of the FDA-required cardiovascular outcomes trial, or CVOT, lorcaserin’s impact on cardiovascular outcomes and effect on conversion to type 2 diabetes.
Executive Officers ‹ Arena Pharmaceuticals
http://www.arenapharm.com/executive-officers
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Director, President and Chief Executive Officer. Craig M. Audet, Ph.D. Senior Vice President, Operations and Head of Global Regulatory Affairs. Executive Vice President and Chief Business Officer. Dominic P. Behan, Ph.D., D.Sc. Director, Co-Founder, Executive Vice President and Chief Scientific Officer.
APD371 ‹ Arena Pharmaceuticals
http://www.arenapharm.com/apd371
Arena Pharmaceuticals, Inc. You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites. Drug Candidate for Treatment of Pain. We have completed a randomized, double-blind and placebo-controlled Phase 1b clinical trial to evaluate the safety, tolerability and pharmacokinetics of multiple-ascending doses of APD371. Phase 1 Program Completed. This page last updated: 5/10/2016.
TOTAL LINKS TO THIS WEBSITE
144
Инвестиционный портал Алтайского края
Инфраструктура для размещения бизнеса. Заявка на размещение производства. Меры государственной поддержки инвесторов. Меры государственной поддержки субъектов малого и среднего предпринимательства. Поддержка резидентов территорий с особым юридическим статусом. Меры государственной поддержки в сфере сельскохозяйственного производства Алтайского края. Экспертный совет по улучшению инвестиционного климата. КАУ Алтайский центр государственно-частного партнерства и привлечения инвестиций. Малый и средний бизнес.
TV & Online Business Crowdfunding & Equity Funding Platform
This login form is for Investment managers only. If you are a donor or general user, you do not need to create an account to make a contribution. Invest in Active Deals. Invest in America's Crowd Fund. Register as Accredited Investor. BROWSE BY INDUSTRY and OWNER TYPE. BROWSE BY STAGE OF BUSINESS. Popular (# of Voters). By America's Crowd Fund I, L.P. The Fund will invest in companies found on crowdfunding platforms, Am . Read More ». Business-to-Business, Technology, Seasoned Entrepreneurs. PPM Funding ...
Инвестиционный портал МО Брюховецкий район
Сегодня 16 августа, воскресенье. Инвесторам - телефон для справок. 18 мая понедельник Муниципальные новости в сфере инвестиций и малого бизнеса. ПРЕДСТАВИТЕЛЕЙ ДЕЛОВЫХ КРУГОВ КУБАНИ ПРИГЛАШАЮТ НА РОССИЙСКО-КАНАДСКУЮ КОНФЕРЕНЦИЮ. 18 мая понедельник Анонсы и итоги выставочных, имиджевых и иных мероприятий в сфере инвестиций и малого бизнеса. КУБАНСКИЕ КОМПАНИИ, ПРОИЗВОДИТЕЛЕЙ ПРИГЛАШАЮТ НА МЕЖДУНАРОДНУЮ СПЕЦИАЛИЗИРОВАННУЮ ВЫСТАВКУ ИМПОРТОЗАМЕЩЕНИЕ. Объекты развлечений и досуга. Площадь, м кв. В муниципальн...
Перспективы развития финансовой системы современности.
В совокупности они имеют общее название "новые финансовые технологии" (НФТ). Их исследование и является основной темой данного информационного ресурса. Сургут поможет (Ведомости, 16.01.2015г.) проект БТС-2 "Транснефти". ЗАЛОЖИТЬ, ЧТОБЫ ПОСТРОИТЬ (Банковское обозрение, 01.09.2014г.). Принципы и организационные формы комплексного инжиниринга энергетических объектов (Журнал ЭнергоРынок, 25.08.2014г.). КАЗАХСТАНСКИЙ БИЗНЕС АТОМНАЯ ЭНЕРГЕТИКА - Учебу оплатим ураном (Эксперт (Россия), 17.01.2014г.). ГОСУДАРСТВ...
Suspended Domain
This account has been suspended. Either the domain has been overused, or the reseller ran out of resources.
Investors | Arena Pharmaceuticals, Inc.
Skip to main navigation. BELVIQ / BELVIQ XR. Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:. Advancing our proprietary clinical programs. Reverse Stock Split - Form 8937. Mar 27, 2018. 17th Annual Needham Healthcare Conference. Mar 19, 2018. Etrasimod Phase 2 in Ulcerative Colitis OASIS Clinical Trial Results Call. Annual Report and Proxy Statement.
Инвестирование в реальный бизнес: прокат автомобилей
Инвестиции в автомобильный бизнес. Получайте деньги от аренды автомобиля. С гарантией его сохранности и без затрат. Ваш доход в месяц:. Эконом класс от 27 650 руб. Средний класс от 41 780 руб. Бизнес класс от 67 970 руб. Премиум класс от 127 970 руб. Сдайте автомобиль в аренду сегодня и получайте прибыль уже завтра! В любой момент вы можете забрать свой автомобиль или продать нам по фиксированной цене. Передача АВТО в аренду. 70% прибыли ваши, 30% наши. Срок от 3-х месяцев. Договор, какой договор с вами?
Kapitał na Pomysł - Fundusz Kapitałowy skierowany do innowacyjnych pomysłów
Dzisiaj jest: 30.03.2018. Agencja Rozwoju Pomorza S.A. Na stronie i podstronach. Zapraszamy do współpracy autorów ciekawych, innowacyjnych rozwiązań na wczesnym etapie rozwoju, mających szansę znaleźć komercyjne zastosowanie na rynku nowoczesnych produktów bądź usług. Czekamy na zgłoszenia przede wszystkim od tych pomysłodawców, którzy mają w planach prowadzenie własnego biznesu, posiadają prototyp /MVP bądź zmaterializowane know-how i potrzebują wsparcia finansowego do realizacji swojego pomysłu....
Инвестиционный паспорт Омской области
Официальный портал Омской области. Объем производства с/х продукции (2012 г.). Является высокоразвитым сельскохозяйственным регионом, обладает одним из крупнейших на востоке страны агропромышленным комплексом. Ведущими отраслями сельского хозяйства являются:. Bull; растениеводство (основные виды продукции пшеница, рожь, ячмень, овeс);. Bull; молочное животноводство;. Bull; птицеводство;. Темп роста ВРП 2010/2009 гг. Объем ВРП Омской области. За 2009 год – 336,3 млрд рублей. Темп роста реального объема ВРП.
Welcome!
Ведутся работы. Пожалуйста ожидайте. Ведутся работы. Пожалуйста ожидайте.
East Midlands Business Grants & Investment | Invest Mansfield & Ashfield
Documents & Links. Transport & Logistics. Ashfield & Mansfield. About Ashfield & Mansfield. Land & Investment Zones. Former Sutton Baths Site. Mansfield Woodhouse Station Gateway. Vision West Nottinghamshire College. 80 delegates attended a public sector procurement event at Kings Mill Hospital, Sutton-in-Ashfield to gain tips and advice on win contracts in the public sector. Making the Most of LinkedIn. Tuesday 18th August 2015. Wednesday 19th August 2015. Converting Website Visitors into Sales. Convers...
